Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Carcinoma, Intraductal, Noninfiltrating 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Pain 2Neoplasms 2Breast Carcinoma In Situ 2Arthralgia 2Weight Loss 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Radiation Injuries 1Psoriasis 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Pelvic Inflammatory Disease 1Ovarian Neoplasms 1Osteoarthritis 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Malnutrition 1Lymphoma 1Leukemia 1Fatigue 1Dyspareunia 1Colonic Neoplasms 1Breast Neoplasms, Male 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Laser Therapy 2Water 1Testosterone 1Sodium Chloride 1Physical Therapy Modalities 1Fish Oils 1Fatty Acids, Omega-3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Dyspareunia × Fatty Acids, Omega-3 × Clear all
NCT02150525 2018-08-09

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
52 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Dyspareunia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡